MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Modifying Effect of a Long-term Repeated Therapy of repetitive Transcranial Magnetic Stimulation combined with Lidocaine Injection (rTMS-LI) on Dystonia

N. Murase, R. Urushihara, S. Matsumoto, K. Sato, K. Asanuma, H. Shimazu, R. Kaji (Nara city, Japan)

Meeting: 2025 International Congress

Keywords: Dystonia: Treatment, Repetitive transcranial magnetic stimulation(rTMS)

Category: Dystonia: Clinical Trials

Objective: To explore whether the therapy of repetitive transcranial magnetic stimulation (rTMS) combined with lidocaine injection (rTMS-LI) just after rTMS has a modifying or a curative effect on dystonia.

Background: We reported an acute effect of rTMS (0.2 Hz over the premotor cortex, 250 stimuli per one session; Murase N et al., 2005) on writer’s cramp. Lidocaine injection with dehydrated ethanol was also effective on writer’s cramp based on the function of the block of sensory afferent fibers in muscle spindles (Muscle afferent block (MAB): Kaji R et al., 1995). Because rTMS retained its effect longer in the patients who had already been treated by MAB than in the treatment-naïve patients in the preliminary trials, we began to try rTMS-LI therapy, expecting the long-term effect, probably based on the similar mechanism of phase-dependent plasticity from premotor cortex followed by peripheral sensory input. The randomized controlled trial for six months-repeated therapy to compare the effect of rTMS-LI with botulinum neurotoxin (BoNT) and MAB, unveiled almost the same long-term effect of rTMS-LI with BoNT than MAB (n = 109; in preparation). Then to explore whether the rTMS-LI for dystonia has a modifying or a curative effect, we observed the patients with repeated rTMS-LI therapy for more than four years.

Method: Six dystonia patients (one upper limb dystonia, three writer’s cramp, one musician’s cramp, one Meige syndrome) who showed long-term rTMS-LI effect were enrolled (mean age 34.2 (SD 7.6) years old, disease duration 4.5 (2.29 years). rTMS-LI was administered monthly and originally modified BFM scale was used. The follow-up period was from four to twenty-one years (10.0 (6.3)). This is the single trial open-label study.

Results: All the patients without one showed sable improvement by the long-term repeated rTMS-LI and the modified BFM scale improved from 5.5 (3.1) before to 2.2 (0.7) after in the best condition. However, there were no patients who showed complete remission. One male patient showed marked worsening when he got promoted and overworked. He then gained complete remission by ablation surgery.

Conclusion: Monthly therapy of rTMS-LI has a modifying but not a curative effect on dystonia.

To cite this abstract in AMA style:

N. Murase, R. Urushihara, S. Matsumoto, K. Sato, K. Asanuma, H. Shimazu, R. Kaji. Modifying Effect of a Long-term Repeated Therapy of repetitive Transcranial Magnetic Stimulation combined with Lidocaine Injection (rTMS-LI) on Dystonia [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/modifying-effect-of-a-long-term-repeated-therapy-of-repetitive-transcranial-magnetic-stimulation-combined-with-lidocaine-injection-rtms-li-on-dystonia/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/modifying-effect-of-a-long-term-repeated-therapy-of-repetitive-transcranial-magnetic-stimulation-combined-with-lidocaine-injection-rtms-li-on-dystonia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley